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Protein phosphatase type 2A (PP2A) is a major Ser/Thr phosphatase involved in several cellular signal transduction pathways. In this
review, we will focus on recent progress concerning the role of PP2A in apoptotic signalling. Since PP2A activates pro-apoptotic and inhibits
anti-apoptotic proteins of the Bcl-2 family, we conclude that PP2A has a positive regulatory function in apoptosis. However, in Drosophila, a
specific subset of the PP2A holoenzyme family, containing BV/PR61 as third regulatory subunit, is inhibitory for apoptosis, suggesting
different regulatory mechanisms and substrates in different species. Moreover, PP2A acts not only upstream as a regulator of the apoptotic
signal transduction pathway but also downstream as a substrate of effector caspases. Hence, PP2A is involved in the regulation as well as in
the cellular response of apoptosis. Probably, various PP2A holoenzymes with distinct regulatory subunits specifically target different
apoptotic substrates. This could explain the implication of PP2A at several levels of the apoptotic signal transduction pathway. Finally, some
viral proteins such as adenovirus E4orf4 and simian virus small t target PP2A to alter its activity, resulting in induction of apoptosis as a
regulatory mechanism to enhance virus spread.D 2003 Elsevier Science B.V. All rights reserved.Keywords: Apoptosis; Protein phosphatase; PP2A; Bcl-2 family; Caspase; Viral protein1. Introduction
Apoptosis is now recognised as an active intracellular
signal transduction pathway by which the cell regulates its
own death. Therefore, apoptosis is synonymous to pro-
grammed cell death and is required for the elimination of
harmful cells and for cell turnover during embryonic develop-
ment and tissue homeostasis. The apoptotic signal trans-
duction pathway is tightly regulated, since dysregulation
leads to pathologies including cancer and auto-immune
diseases (loss of apoptotic function) or neurodegenerative
disorders, hepatitis and other diseases linked to inappropriate
gain of apoptotic function [1,2]. Apoptosis is induced by a
variety of physiological and pathological environmental and
intracellular factors. Depending on the cell type and cellular
context, many signalling systems can be activated, all con-
verging into one common signal transduction pathway [3].
Binding of death-activating ligands of the TNF family to the
extracellular surface of cell death receptors (extrinsic) or0167-4889/03/$ - see front matter D 2003 Elsevier Science B.V. All rights reserv
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Bcl-2 family at the mitochondrial membrane (intrinsic) leads
to the mitochondrial release of cytochrome c. Cytochrome c
serves together with ATP as cofactor of apoptosis protease
activating factor-1 (Apaf-1), a pro-apoptotic protein required
for the activation of caspases, the executioners of the apop-
totic response [3–6]. These effector caspases are specific
proteases, mediating the morphological changes character-
istic for apoptotic cell death such as membrane blebbing and
formation of apoptotic vesicles, cytoplasmic shrinkage as
well as nuclear condensation and DNA fragmentation [7–9].
Like many physiological processes, commitment to apop-
tosis is posttranslationally regulated by reversible phosphor-
ylation of apoptotic signalling proteins and therefore
controlled by a balance in protein kinase and protein phos-
phatase activity. Protein kinases implicated in the prevention
or generation of apoptotic signals are already identified,
whereas the counter-regulatory protein phosphatases are less
well defined. Currently, serine/threonine phosphatases con-
sist of the PPP and PPM family, based on the similarity of
their primary structure. The PPP family is further subdivided
in the PP1, PP2A (including the PP2A-like phosphatases PP4ed.
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families, based on their substrate specificity and sensitivity to
specific inhibitors or effectors [10]. Phosphorylation of intra-
cellular proteins mostly occurs on Ser and Thr residues and
PP2A accounts for a significant fraction of Ser/Thr phospha-
tase activity in most cell types. The core structure is a dimer
(PP2AD), consisting of a 36-kDa catalytic subunit (PP2AC)
and a 65-kDa anchoring A subunit. A third regulatory B
subunit can associate with this core enzyme. These regulatory
B subunits are encoded by three multigene families referred
to as B/PR55, BV/PR61 and BU/PR72 [11], and confer distinct
properties to the PP2A holoenzyme. In this way, different
holoenzyme assemblies dephosphorylate distinct substrates
in different cellular compartments, resulting in diverse cel-
lular functions of PP2A. The generation of an extraordinary
diversity of PP2A holoenzymes might explain the important
role of PP2A in a variety of signalling pathways by regulating
the activity of protein kinases, protein phosphatases or their
substrates [12]. In this review, we will summarise the current
knowledge on the role of PP2A in the apoptotic signal
transduction pathway.2. PP2A as a regulator of the Bcl-2 family
The Bcl-2 family, named after the founder of this family,
consists of pro- and anti-apoptotic proteins residing at the
mitochondrial outer membrane. By integrating signals fromFig. 1. Regulatory role of PP2A in the apoptotic signal transduction pathway upstr
of the BV/PR61 subunit, resulting in the assembly of a mitochondrial PP2A holoen
PP2A is also a Bad phosphatase, keeping this pro-apoptotic protein in a dephosph
Bcl-2. The net result is the release of cytochrome c, required for the apoptotic re
Therefore, the third BV/PR61 subunit is presented by dashed lines.survival factors and death stimuli, they guard the mitochon-
drial gate against the release of apoptotic activators and the
subsequent activation of effector caspases. Their activities
are regulated by different mechanisms such as homo- and
heterodimerisation with other family members, but also by
posttranslational modifications such as phosphorylation and
proteolysis [6]. Hence, the co-ordinated action of kinases
and phosphatases in response to survival or apoptotic
stimuli modulates the Bcl-2 family activity. The role of
PP2A in this regulatory mechanism is here discussed and
illustrated in Fig. 1.
2.1. Inactivation of anti-apoptotic Bcl-2 protein
The prototype of this family, Bcl-2 was first identified as a
proto-oncogene in B-cell lymphoma and subsequently rec-
ognised as the mammalian homologue of the apoptotic
inhibitor ced-9 in C. elegans. Accordingly, Bcl-2 is an anti-
apoptotic member of this family and promotes cell survival.
Although the role of phosphorylation of Bcl-2 for its anti-
apoptotic function was controversial for a long time, there is
growing evidence that phosphorylation regulates Bcl-2 activ-
ity. However, the functional consequence of Bcl-2 phosphor-
ylation seems to be dependent on the nature of the stimulus,
the site of phosphorylation and the cellular context such as
cell type, cell cycle state, subcellular localisation of Bcl-2,
etc. [13]. In the case of growth factor stimulation by IL-3,
Bcl-2 becomes phosphorylated on an evolutionary conservedeam of the Bcl-2 family. Ceramide induces the expression and translocation
zyme dephosphorylating and inactivating the anti-apoptotic Bcl-2 at Ser70.
orylated and mitochondrial located state, where it is functional in inhibiting
sponse. The composition of the Bad PP2A holoenzyme is not yet defined.
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and potent apoptosis-suppressing activity of Bcl-2. Mito-
chondrial protein kinase Ca (PKC) and the mitogen-activated
protein kinases (MAPK) ERK1, ERK2 and the c-Jun N-
terminal kinase, JNK1, but not p38 MAPK, are identified as
physiological Bcl-2 activating kinases, phosphorylating Bcl-
2 on this Ser70 residue [14–16]. On the other hand, PP2A is
found to be the Bcl-2 inactivating phosphatase, based on
several arguments. First, phosphorylation of Ser70 by an
agonist-activated Bcl-2 kinase is required for direct Bcl-2-
PP2A interaction and subsequent dephosphorylation of Bcl-2
by PP2A [17]. Second, ceramide, a second messenger in
apoptotic signalling, is also known to activate a phosphatase,
CAPP, which has been biochemically characterised as a
PP2A dimeric or trimeric enzyme associated with a B/PR55
or BV/PR61 third regulatory subunit [18]. The mechanism for
ceramide-induced apoptosis involves the specific activation
of a mitochondrial PP2A that dephosphorylates and inacti-
vates Bcl-2, since dephosphorylation of Bcl-2 by a highly
okadaic acid-sensitive phosphatase is required for ceramide-
induced apoptosis [19]. The identification of PP2A as the
ceramide-activated phosphatase (CAPP) as well as the phys-
iological Bcl-2 phosphatase was further sustained by identi-
fication of the PP2A holoenzyme involved in ceramide-
induced Bcl-2 dephosphorylation. The mitochondrial PP2A
activity involved in the dephosphorylation of Bcl-2 is a
trimeric enzyme containing BV/PR61a as the third regulatory
subunit, since BV/PR61a directly interacts and co-localises
with Bcl-2 in the mitochondrial membranes. Moreover,
ceramide upregulates the BV/PR61a expression and promotes
its translocation to mitochondrial membranes. Finally, BV/
PR61a overexpression promotes the activity of the Bcl-2
phosphatase in a ceramide-responsive manner [20]. All these
results indicate a pro-apoptotic function for PP2A containing
the BV/PR61a regulatory subunit by dephosphorylating and
inactivating the anti-apoptotic Bcl-2 protein.
However, data from genetic analysis in Drosophila
indicate that PP2A might be operational in alternative
apoptotic pathways or that insect apoptotic pathways devi-
ate substantially from those in mammals. Indeed, global
knockdown of PP2A activity or specific loss of the redun-
dant BV/PR61 regulatory subunits in Drosophila by RNA
interference (RNAi) caused cell death with the morpholog-
ical and biochemical changes characteristic for apoptosis
[21,22]. This would implicate an anti-apoptotic activity of
PP2A in Drosophila, specifically mediated by the BV/PR61
regulatory subunit. RNAi of both BV/PR61 subunits in
combination with a knock down of the effector caspase
Drice, the Drosophila homologue of Apaf-1 (Dark) or dp53,
places BV/PR61-regulated PP2A upstream of these apoptotic
signalling proteins. A similar approach lead to the upstream
position of BV/PR61 to the apoptotic regulators reaper and
hid (head involution defective), but not to grim in the
Drosophila apoptotic pathway. These three proteins are
encoded by tightly linked genes, which control apoptosis
during Drosophila embryonic development. They appear tointegrate upstream signals in an alternative apoptotic path-
way, different from the classical apoptotic signal trans-
duction pathway, based on the C. elegans model [23]. So
far, no structural homologues for these proteins are found in
mammals. Nevertheless, expression of reaper, grim or hid in
vertebrate systems causes apoptosis, suggesting that at least
their function is conserved. Therefore, the apparent contra-
diction in the role of BV/PR61 containing trimeric PP2A in
apoptosis in different organisms can at least partially be
explained by species differences of the apoptotic apparatus.
Moreover, the only gene product in Drosophila related to
Bcl-2 is the pro-apoptotic factor, dBOK. Its ablation does
not block BV/PR61-knockdown-induced apoptosis, implicat-
ing that PP2A’s modulation of apoptosis in Drosophila is
independent of the regulation of Bcl-2, although PP2A has
been shown to affect caspase activity [22]. These results
suggest a different target and function of PP2A in the
Drosophila apoptotic signal transduction pathway compared
to mammals. Alternatively, interaction of PP2A with other
proteins might modulate PP2A activity towards specific
substrates in apoptotic signalling. For instance, cyclin G1
has been shown to interact with trimeric PP2A containing
the BV/PR61 subunit in a p53-dependent way [24,25]. This
quaternary PP2A complex is enzymatically active and
cyclin G1 recruits PP2A to dephosphorylate its binding
partner Mdm2 at Thr216. Mdm2 negatively regulates p53,
a pro-apoptotic transcription factor inducing cyclin G1
transcription. Dephosphorylation of this Mdm2 site by
cyclin G1-directed PP2A is thought to activate Mdm2,
resulting in the degradation of p53 [25]. This mechanism
of action through interaction with cyclin G1 might explain
the anti-apoptotic effect of BV/PR61 containing PP2A
upstream of dp53 in Drosophila. However, in this organism
cyclin G1 might direct PP2A to another pro-survival target,
since no homologue of Mdm2 is identified in Drosophila.
The balance between pro-survival and pro-apoptotic
signalling is very sophisticated and it is not uncommon that
the same signalling molecules function in both pathways.
The integration of the complex web of incoming signals will
ultimately determine the swing over of the balance in the
direction of cell proliferation or cell death.
2.2. Activation of pro-apoptotic Bad protein
Bad is a pro-apoptotic member of the Bcl-2 family,
whose function is highly regulated by reversible phosphor-
ylation. Dependent on the survival stimuli and cell type, Bad
becomes phosphorylated at Ser112, Ser136 and/or Ser155 by
different pro-survival kinases such as mitochondrial cAMP-
dependent protein kinase (PK-A) and cytosolic PK-B/Akt,
which co-operatively mediate binding of Bad to 14-3-3
proteins. 14-3-3 interaction leads to cytoplasmic retention
of Bad and interferes with the ability of Bad to translocate to
the mitochondrial membrane and to heterodimerise with and
inhibit the anti-apoptotic Bcl-2 protein. In the absence of
survival stimuli, Bad is dephosphorylated and co-localises
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drial membrane via its Bcl-2 homology 3 (BH3) domain,
leading to apoptotic cell death [26,27]. Hence, several
investigators made the effort to identify the physiological
pro-apoptotic Bad phosphatase. On interleukin-3 (IL-3)
withdrawal, Bad is rapidly dephosphorylated by PP2A.
However, dissociation of 14-3-3 from Bad is a prerequisite
for Bad dephosphorylation, suggesting that posttranslational
modifications on the 14-3-3 protein such as phosphorylation
and subsequent proteolysis by caspases rather than primary
Bad dephosphorylation would be responsible for the disso-
ciation of the Bad-14-3-3 interaction [28]. On the other
hand, PP1 as well as calcineurin (PP2B) are also reported to
be Bad phosphatases in vivo. Dephosphorylation of Bad by
PP1 after IL-2 or IL-4 withdrawal was 14-3-3-independent
[29], but dependent on the interaction of PP1 with anti-
apoptotic members of the Bcl-2 family (Bcl-2, Bcl-w and
Bcl-xL). They all contain an RXVXF PP1-binding motif
[30,31]. In hippocampal neurons, an increased Ca2 + influx
and subsequent calcineurin activation results in dephosphor-
ylation of Bad. This correlates with its dissociation from 14-
3-3 proteins and translocation from the cytosol to the
mitochondria, resulting in an apoptotic cellular response
[32]. Hence, different phosphatases seem to be involved inFig. 2. Schematic presentation of the caspase cascades activated by apoptotic sig
induce the formation of a Death Inducing Signalling Complex (DISC), leading to
apoptotic Bcl-2 family member Bid, activating the intrinsic pathway or directly c
pathway, apoptotic signals sensed by the Bcl-2 family at the mitochondrial memb
Apaf-1, eliciting the recruitment of pro-caspase 9 in this apoptosome complex,
signalling pathway cleave and subsequently activate effector caspases, responsible
response by cleaving cellular substrates involved in the apoptotic morphology chan
to be the A/PR65 subunit of PP2A. Degradation of this regulatory PP2A subunit alt
a specific regulatory protein) towards unidentified substrates, resulting in the proBad dephosphorylation, dependent on the subcellular loca-
tion of Bad and specificity for Bad associated with other
proteins such as 14-3-3 in the cytosol or Bcl-2 in the
mitochondria. Furthermore, regulation of Bad dephosphor-
ylation seems to be dependent on the cellular context,
consistent with the ability of different cell types to respond
to different survival factors or apoptotic stimuli.3. PP2A as a substrate of caspases
Caspases are Cys-dependent Asp-specific proteases,
important for the specific cleavage of signalling proteins
involved in the regulation and execution of inflammatory
and apoptotic responses. Caspases are divided into three
groups, based on their structure and biological function.
Caspase 1, 4 and 5 are not involved in apoptosis, but in
cytokine activation, while the apoptotic caspases are further
subdivided into initiator and effector caspases. Caspase 8
and 10 are initiator caspases of the extrinsic apoptotic signal
transduction pathway, activated by binding of ligand to cell
death receptors. Their auto-activation results in direct cleav-
age of effector caspases or activation of the intrinsic signal-
ling pathway by cleaving and activating the pro-apoptoticnals. In the extrinsic apoptotic pathway, ligand binding to death receptors
the activation of initiator caspases 8 or 10. These caspases cleave the pro-
leave and activate the effector caspases 3 and 7. In the intrinsic signalling
rane result in the release of cytochrome c. Cytochrome c and ATP bind to
causing its activation. Both initiator caspases of the intrinsic and extrinsic
for auto-amplification of the cascade as well as execution of the apoptotic
ges of the cell. One of the cellular substrates for effector caspase 3 is shown
ers the PP2A activity of the catalytic subunit (whether or not associated with
motion of the apoptotic response.
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results in cytochrome c release from the mitochondria into
the cytosol and subsequent activation of caspase 9 by Apaf-
1. Caspase 9 is the initiator caspase of this intrinsic signal
transduction pathway, frequently activated by cellular stress
signals. Its auto-catalysis in the apoptosome (cytochrome c/
Apaf-1/pro-caspase 9 complex) results in the direct activa-
tion of effector caspases 3 and 7. Caspase 3 subsequently
activates the effector caspases 6 and 2. All these effector
caspases also cleave death substrates responsible for the
characteristic apoptotic morphology or regulatory proteins
resulting in the auto-amplification of the apoptotic signal
[7,8]. This apoptotic caspase cascade is illustrated in Fig. 2.
By screening for substrates specific for effector caspase-3,
the A/PR65 subunit of PP2A was found to be cleaved by
caspase-3. This is consistent with the presence of a caspase-
3-specific cleaving consensus sequence in the A/PR65 C-
terminal domain [33], correlating with the size of the cleaved
product. Cleaving by caspase-3 results in an increase in in
vitro PP2A activity towards a synthetic peptide. In vivo,
cleavage of the A/PR65 subunit and an increase in PP2A
activity is correlated with the commitment of cells to
apoptosis by specific activation of caspase-3 [34]. Hence,
partial or total loss (by further degradation) of the A/PR65
subunit resulted in an increase in PP2A activity towards
specific pro-apoptotic substrates involved in the cellular
apoptotic response. However, the physiological targets of
this free pro-apoptotic PP2A catalytic subunit (PP2AC) are
not known. Alternatively, after removal of the A/PR65Fig. 3. Interaction of viral proteins with different PP2A holoenzymes. Association
activity towards not yet identified substrates involved in induction of apoptosis.
functions such as transcriptional down-regulation or alternative mRNA splicing
functions. In contrast, small t binds PP2A by replacing the B subunit family, result
decreased dephosphorylation of growth promoting PP2A results in enhanced cell t
in PP2A activity results in apoptosis by inhibition of the dephosphorylation of nosubunit, PP2AC associates with other regulatory proteins
altering the PP2A activity towards specific substrates, as is
already shown for the PP2AC-a4 complex in the TOR signal
transduction pathway [35]. Moreover, these data demon-
strate that PP2A acts in the apoptotic signal transduction
pathway not only upstream but also downstream of the
effector caspases. Hence, PP2A is involved in the regulation
as well as the cellular response of apoptosis. Probably,
various PP2A holoenzymes with distinct regulatory subunits
altering the PP2A substrate specificity are implicated at
different levels of the apoptotic signal transduction pathway.4. PP2A as a mediator of virally induced apoptosis
In addition to apoptosis in response to ligand activation
of cell death receptors and cellular stress, viral infection also
provokes cell death as a host defence mechanism that limits
viral replication by killing virally infected cells. On the
other hand, viruses use strategies to evade this apoptotic
response to allow production of high yields of progeny.
They inhibit apoptosis by encoding anti-apoptotic viral Bcl-
2 homologues or inhibitors of caspases (e.g. crmA, p35),
thereby directly interfering with the host components of the
apoptotic signal transduction pathway. However, at later
stages of infection, viruses induce apoptosis as a mechanism
of cell killing to enhance virus spread [36,37]. Some of
these viral proteins target PP2A as a strategy to activate the
apoptotic signal transduction pathway (Fig. 3).of E4orf4 with the B/PR55 subunit of PP2A results in an increase in PP2A
E4orf4 also interacts with the BV/PR61 subunit, mediating different E4orf4
by altering PP2A activity towards specific substrates involved in these
ing in inhibition of the PP2A activity towards specific substrates. Normally,
ransformation. However, in some cellular contexts, small t-directed decrease
t yet identified apoptotic substrates.
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apoptosis, whereas the E1B55K and E4orf6 proteins inhibit
E1A long enough to allow high virus yields. E1A-induced
apoptosis is p53-dependent. Enhanced stabilisation and acti-
vation of p53 by E1A is subsequently counteracted by
inhibition of p53 function by E1B55K and E4orf6 [37]. In
addition, another viral product of the E4 transcription unit,
E4orf4 also induces apoptosis in a p53-independent pathway,
but only in transformed cells and not in normal cells. This
makes E4orf4 a potentially useful tool for cancer gene
therapy. Moreover, E4orf4-induced apoptosis is independent
of the activation of caspases in most but not all cell lines
[38,39]. E4orf4 associates with and activates PP2A by direct
binding to the B/PR55 regulatory subunit [40]. Although the
apoptotic signal transduction pathway activated by E4orf4 is
not yet elucidated, the correlation between the ability of
E4orf4 to complex PP2A and to induce apoptosis is demon-
strated by two independent laboratories [41,42]. In addition,
E4orf4 can also interact with the BV/PR61 regulatory subunit
of PP2A, but this interaction does not induce E4orf4-medi-
ated cell killing [43]. These results indicate that E4orf4
specifically requires binding to the B/PR55 regulatory sub-
unit to induce cell death. Hence, also in E4orf4-mediated
apoptosis, PP2A has a pro-apoptotic function. The PP2A
holoenzyme containing the BV/PR61 regulatory subunit com-
plexed to E4orf4 might be involved in other viral functions of
E4orf4 such as down-regulation of virus-stimulated tran-
scription [40,44] and of alternative splicing [45].
Papovae viruses encode antigen products required for
virally mediated transformation and replication. PP2A inter-
acts with simian virus 40 (SV40) small t antigen and
polyoma virus small t and middle T antigens [46]. The
interaction of small t with PP2A inhibits PP2A activity
towards some substrates both in vitro and in vivo, probably
by replacing the B subunit. This leads to hyperphosphor-
ylation and reactivation of PP2A substrates involved in the
promotion of signal transduction pathways activating cell
growth and auxiliary for transformation of virus-infected
cells [47,48]. On the other hand, small t is also reported to
induce apoptosis, depending on conditions and cell type.
Also this small t function is dependent on its interaction
with PP2A [49]. This suggests that small t inhibits a survival
function of PP2A, resulting in apoptosis. This is in contrast
with the proposed pro-apoptotic function of PP2A based on
all other observations in mammalian systems. Furthermore,
the physiological significance of this data is not clear, since
small t does not induce apoptosis in its natural host cell.5. Conclusions and perspectives
In mammalian systems, a pro-apoptotic function of PP2A
becomes obvious, based on the multiple observations dem-
onstrating a positive regulatory role for PP2A in apoptosis
by activating pro-apoptotic and inhibiting anti-apoptotic
proteins by dephosphorylation. The specific targeting ofseveral different apoptotic substrates might be accomplished
by different PP2A holoenzymes, containing distinct third
regulatory subunit isoforms. For instance, the BV/PR61
subunit confers specificity to Bcl-2. This is in contrast with
the clearly demonstrated anti-apoptotic role for this protein
in Drosophila, indicating that in this organism PP2A is
functioning in a different apoptotic signal transduction
pathway. The pro-apoptotic role of PP2A is consistent with
its inhibitory role in cell cycle progression, cell growth and
cell survival, by inhibiting either directly or indirectly cdc2
kinase, MAP kinase and PK-B/Akt kinase, respectively. In
this context, a tumour suppressor function of PP2A is
predicted, since genetic alterations [50] or reduced expres-
sion [51] of A/PR65 is found in several human cancers, all
impaired in PP2A subunit assembly and phosphatase activ-
ity. More recently, reduction of BV/PR61 expression is
reported to be associated with malignant melanomas [52].
Also PP2A activity towards RelA, an NF-nB transcription
factor involved in pro-survival responses, is shown to be
decreased in melanoma cells vs. normal melanocytes, result-
ing in an increased phosphorylation and transactivation
activity of RelA [53]. Characterisation of the specific
physiological substrates and the regulation of PP2A hol-
oenzyme assembly will be one of the main topics to identify
the in vivo function and regulation of PP2A in the apoptotic
and other signal transduction pathways.Acknowledgements
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